Pharmacy Week in Review: Women Pharmacist Day Celebrated, FDA OKs Expanded HPV Vaccine Use

A look at last week's top stories in the world of pharmacy.


Nicole Grassano, Host: Hello and welcome to the Pharmacy Times News Network. I’m Nicole Grassano your host for our Pharmacy Week in Review.

The inaugural Women Pharmacist Day will be commemorated today, in conjunction with National Pharmacist Month, to recognize the important contributions female pharmacists make every day to deliver quality care to patients, and conference organizers at the National Community Pharmacist's Association Annual Convention last weekend reminded pharmacists to celebrate, Pharmacy Times reported.

Although women made up just 8% of all US pharmacists as recently as the 1960s, women now comprise 55% of the pharmacist workforce, and the number of those practicing is on the rise. About 61% of the 14,000 PharmDs earned in the US in 2016 were earned by women, according to a recent statement from Cardinal Health, a Women Pharmacist Day sponsor.

NCPA conference organizers said that Women Pharmacist Day is an excellent opportunity to celebrate the significant gains women have made in pursuing careers in pharmacy, while honoring the trailblazers who have made such progress possible. 

FDA officials have approved a supplemental application for Merck's Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) that expands the approved use of the vaccine to include individuals aged 27 to 45 years, Contemporary Clinic reported. The vaccine prevents certain cancers and diseases caused by 9 HPV types.

Every year about 14 million Americans become infected with HPV, and about 12,000 women are diagnosed with and about 4,000 women die from cervical cancer caused by certain HPV viruses, according to the CDC. HPV viruses also are associated with several other forms of cancer that affect men and women.

Type 2 diabetes remains the most common type of diabetes diagnosed in American adults, but rates are increasing among both disease subtypes, Specialty Pharmacy Times reported. A study published in the British Medical Journal used data from the CDC’s National Health Interview Survey to determine how many adults have each type of diabetes in the United States.

The prevalence of diabetes among US adults has been reported in previous studies, but data on the prevalence by subtype have been relatively unknown. Individuals with both type 1 and type 2 diabetes have difficulties producing insulin and require treatment with it for survival.

Pharmacists may get more questions about MiraLAX if their patients have seen a new commercial for the OTC medication. In the spot, called “A Different Solution,” a man says he never knew of a different solution for his constipation until his doctor recommended MiraLAX.

According to the commercial, unlike Dulcolax, Ex-Lax, and Senokot, which stimulate the nerves of the colon, MiraLAX works with the water in the body to unblock naturally.

For more great coverage and practical information for today’s pharmacist, visit our website and sign up for our Daily eNews. And don’t forget to follow us on Facebook, Twitter, and Instagram.

Thanks for watching our Pharmacy Week in Review. I’m Nicole Grassano at the Pharmacy Times News Network.

Related Articles

African Americans can frequently experience barriers in seeking out lifesaving clinical trials for cancer treatments.
Top news of the day from across the health care landscape.
Top news of the week from Specialty Pharmacy Times.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.